Is KMS Medisurgi overvalued or undervalued?
As of June 27, 2025, KMS Medisurgi is considered very expensive with a PE ratio of 41.91, significantly overvalued compared to peers like Poly Medicure and Vimta Labs, and has underperformed the Sensex with a year-to-date return of only 1.6%.
As of 27 June 2025, KMS Medisurgi's valuation grade has moved from risky to very expensive, indicating a significant shift in its perceived market value. The company is currently overvalued, with a PE ratio of 41.91, an EV to EBIT ratio of 42.03, and a Price to Book Value of 5.47. These ratios suggest that investors are paying a premium for the stock compared to its earnings and book value.In comparison to its peers, KMS Medisurgi's valuation stands out as particularly high. For instance, Poly Medicure has a PE ratio of 64.67, while Vimta Labs is more reasonably valued at 31.91. This stark difference highlights KMS Medisurgi's overvaluation in the current market. Additionally, the company's recent stock performance has lagged behind the Sensex, with a year-to-date return of 1.6% compared to the Sensex's 7.58%, further reinforcing the notion that the stock is overpriced relative to its fundamentals.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
